RICT 2015
Drug Discovery and Selection

Understanding Targets and Mechanisms

51st International Conference on Medicinal Chemistry
51èmes Rencontres Internationales de Chimie Thérapeutique

 Avignon, France    July 1-3, 2015

Committees


Executive Committee

Members

Dr C. CONTINO-PEPIN

University of Avignon, Avignon, France

Prof. P. DALLEMAGNE

University of Caen, Caen, France

Dr G. DURAND

University of Avignon, Avignon, France

Prof. H. GALONS

SCT & Paris Descartes University, Paris, France

Dr P. GEORGE

SCT & Independent Scientific Expert & Adviser, Longvilliers, France

Prof. A. POLIDORI

University of Avignon, Avignon, France

Prof. J. SAPI

SCT & University of Reims-Champagne-Ardenne, Reims, France

Dr L. VAN HIJFTE

SCT & NovAliX, Nijmegen, The Netherlands

Local Organising Committee

Members

Mrs A. BARRIERE

Maison de la Recherche, University of Avignon, Avignon, France

Dr F. BONNETE

CNRS, Institut des Biomolécules Max Mousseron (IBMM)-University of Avignon, Avignon, France

Dr C. CONTINO-PEPIN

University of Avignon, Avignon, France

Dr G. DURAND

University of Avignon, Avignon, France

Dr P. GUILLET

University of Avignon, Avignon, France

Prof. A. POLIDORI

University of Avignon, Avignon, France

Mr S. RAYNAL

University of Avignon, Avignon, France

Mrs V. VIDAU

University of Avignon, Avignon, France

Scientific Advisory Board

Members

Dr J.-L. BANERES

Institut des Biomolécules Max Mousseron (IBMM), Montpellier, France

Prof. R. BUREAU

University of Caen, Caen, France

Dr K. BUSH

Indiana University, Bloomington, United States

Prof. E. M. CARREIRA

ETH Zürich, Zürich, Switzerland

Dr P. CHENE

Novartis, Basel, Switzerland

Dr R. COOKE

Heptares, Hertfordshire, United Kingdom

Dr C. DOUSSON

Idenix Pharmaceuticals, Montpellier, France

Prof. P. DUMY

Ecole Nationale Supérieure de Chimie de Montpellier (ENSCM), Montpellier, France

Prof. E. GIRALT

Institute for Research in Biomedicine (IRB), Barcelona, Spain

Dr J.-C. HARMANGE

Constellation Pharmaceuticals, Cambridge, United States

Dr J.-M. JIMENEZ

Vertex Pharmaceuticals, Abingdon, United Kingdom

Prof. H. KAGECHIKA

Tokyo Medical and Dental University, Tokyo, Japan

Prof. D. KIREEV

University of North Carolina, Chapel Hill, United States

Dr U. LÜCKING

Bayer HealthCare, Berlin, Germany

Dr B. MIROUX

University Paris Diderot - Institut de Biologie Physico-Chimique (IBPC), Paris, France

Prof. J. MITTENDORF

Bayer Pharma AG, Wuppertal, Germany

Prof. N. MIYATA

Nagoya City University, Nagoya, Japan

Dr M. MOUREZ

Sanofi-Pasteur, Lyon, France

Dr M. NILGES

Institut Pasteur, Paris, France

Dr M. OKANIWA

Takeda Pharmaceutical Company, Kanagawa, Japan

Dr J.-M. PAGES

Aix Marseille University, Marseille, France

Prof. E. PEBAY-PEYROULA

University Joseph Fourier, Grenoble, France

Prof. J. ROBINSON

University of Zürich, Zürich, Switzerland

Dr H. SHEN

Roche Innovation Center, Shanghai, China

Dr P. SJÖ

Astrazeneca, Geneva, Switzerland

Prof. H. SUGA

University of Tokyo, Tokyo, Japan

Dr P. P. TAK

GlaxoSmithKline , Brentford, United Kingdom

Dr H. VAN VLIJMEN

Janssen, Beerse, Belgium

Dr R. VAZ

Sanofi-Genzyme, Bridgewater, United States

Prof. S. WANG

University of Michigan, Michigan, United States

Dr G. WECKBECKER

Novartis, Basel, Switzerland

Dr J. Z. ZHU

UCB, Berkshire, United Kingdom